Nu Skin Enterprises (NUS) Current Deferred Revenue (2015 - 2025)

Nu Skin Enterprises has disclosed Current Deferred Revenue across 11 years of filings, most recently posting $12.7 million for Q4 2025.

• Current Deferred Revenue for Q4 2025 came in at $12.7 million, down 18.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $12.7 million (down 18.81% YoY), and the FY2025 annual result was $12.7 million, down 18.81% from the prior year.
• Current Deferred Revenue came in at $12.7 million for Q4 2025 at Nu Skin Enterprises, down from $15.7 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $33.1 million in Q4 2021 to a low of $12.7 million in Q4 2025.
• The 5-year median for Current Deferred Revenue is $20.3 million (2023), against an average of $21.8 million.
• Across the five-year window, Current Deferred Revenue retreated 5.46% in 2021 and slipped 24.82% in 2023, its largest moves.
• Nu Skin Enterprises' Current Deferred Revenue stood at $33.1 million in 2021, then slipped by 18.37% to $27.1 million in 2022, then retreated by 24.82% to $20.3 million in 2023, then fell by 22.86% to $15.7 million in 2024, then dropped by 18.81% to $12.7 million in 2025.
• The last three Current Deferred Revenue figures came in at $12.7 million (Q4 2025), $15.7 million (Q4 2024), and $20.3 million (Q4 2023), per Business Quant data.